Basic info
Industry
pharmaceutical manufacturing
Sectors
Cancer and neurological conditions
Biotechnology
Core technology Sulforadex®
Medical
Pharmaceutical
Commercialising sulforaphane-based pharmaceuticals
Pharmaceuticals
Date founded
2007
Funding rounds raised
Total raised
$2M
from 6 investors over 6 rounds
E
Evgen Pharma raised $2M on September 10, 2015
Investors: Acceleris Capital and Seneca Partners
E
Evgen Pharma raised $713K on July 25, 2012
Investors: SARUM PARTNERS LLP and The North West Fund
E
Evgen Pharma raised undisclosed on September 20, 2011
Investors: The North West Fund
E
Evgen Pharma raised undisclosed on September 1, 2009
Investors: Imprimatur Capital